Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial
Psychosocial Group Intervention to Patients With Primary Breast Cancer - Psychosocial and Survival Outcome From a Randomised Study
1 other identifier
interventional
210
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether an intervention to breast cancer patients including psycho-education and group psychotherapy can enhance quality of life and survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Jan 2004
Typical duration for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 16, 2010
CompletedFirst Posted
Study publicly available on registry
April 21, 2010
CompletedApril 21, 2010
January 1, 2004
2.9 years
February 16, 2010
April 20, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life
Does Quality of Life enhance among a group of primary breast cancer patients who participate in a psychosocial group intervention compared to a control group of primary breast cancer patients who do not recieve any psychosocial intervention?
12 months post intervention
Secondary Outcomes (1)
Survival
5 years post surgery
Study Arms (2)
Psychosocial support
EXPERIMENTALControl group
NO INTERVENTIONInterventions
Psycho-social group intervention including patient-education for 6 h per week for 2 weeks and group therapy 2½ h for 8 weeks
Eligibility Criteria
You may qualify if:
- Eligible patients were 18-70 years of age with stage I-IIIA primary breast cancer
You may not qualify if:
- Distant metastasis
- Not speaking or understanding Danish
- Over 71 years
- Other life-threatening diseases
- Brain-damaged
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ellen H Boesen, MSc, Phd
Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100
- STUDY CHAIR
Christoffer Johansen, DSc (Med)
Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 16, 2010
First Posted
April 21, 2010
Study Start
January 1, 2004
Primary Completion
December 1, 2006
Study Completion
December 1, 2006
Last Updated
April 21, 2010
Record last verified: 2004-01